NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma
NRG/RTOG 0837:一项随机、II期、双盲、安慰剂对照试验,研究化疗联合放疗或不联合西地尼布治疗新诊断的胶质母细胞瘤的疗效。
期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdad116
Batchelor, Tracy T; Won, Minhee; Chakravarti, Arnab; Hadjipanayis, Costas G; Shi, Wenyin; Ashby, Lynn S; Stieber, Volker W; Robins, H Ian; Gray, Heidi J; Voloschin, Alfredo; Fiveash, John B; Robinson, Clifford G; Chamarthy, UshaSree; Kwok, Young; Cescon, Terrence P; Sharma, Anand K; Chaudhary, Rekha; Polley, Mei-Yin; Mehta, Minesh P